1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine has been researched along with Acute Promyelocytic Leukemia in 1 studies
1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine: reported to have same biological activity as natural PAF-acether; RN given refers to parent cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dive, C | 1 |
| Watson, JV | 1 |
| Workman, P | 1 |
1 other study available for 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Division; Cell Membrane Permeability; Flow Cytometry; | 1991 |